Heparin-appended polycaprolactone core/corona nanoparticles for site specific delivery of 5-fluorouracil

被引:7
|
作者
Garg, Ashish [1 ]
Patel, Vaibhav [1 ]
Sharma, Rajeev [2 ]
Jain, Amit [3 ]
Yadav, Awesh K. [3 ]
机构
[1] Guru Ramdas Khalsa Inst Sci & Technol, Drug Delivery & Nanotechnol Labs, Dept Pharmaceut, Pharm, Jabalpur, India
[2] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar, Madhya Pradesh, India
[3] Bhagyoday Tirth Pharm Coll, Dept Pharmaceut, Nanotechnol Project Labs, Sagar, Madhya Pradesh, India
关键词
Cellular cytotoxicity; 5-fluorouracil; heparin; nanoparticles; polycaprolactone; CHOLESTEROL-RICH NANOEMULSION; DRUG-DELIVERY; SIZE DISTRIBUTION; CELLS; LDE;
D O I
10.1080/21691401.2016.1203793
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The aim of the present work is to formulate heparin-modified-polycaprolactone (HEP) core shell nanoparticles (NPs) of 5-fluorouracil (5-FU). These NPs were characterized for various in vitro parameters like particle size, zeta potential, etc. HEP NPs were found to maintain comparatively slower drug release pattern (98.9% in 96h) than PCL NPs. Cytotoxicity studies demonstrated a massive cytotoxic potential of 5-FU-loaded HEP NPs in A549, MDA-MD-435, and SK-OV-3 cancer cell lines. Pharmacokinetic parameters were also determined in blood after IV administration of HEP NPs: AUC, C-max, MRT, and T-max values are 6096.075 +/- 5.90gh/mL, 144.38 +/- 1.52g/L, 58.71 +/- 0.25h, 96 +/- 0.50h, respectively and 117.92 +/- 1.78, 45.35 +/- 3.00, 1.2 +/- 0.25, 0.5 +/- 0.02 in plain 5-FU solution.
引用
收藏
页码:1146 / 1155
页数:10
相关论文
共 50 条
  • [31] PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer
    Handali, Somayeh
    Moghimipour, Eskandar
    Rezaei, Mohsen
    Ramezani, Zahra
    Dorkoosh, Farid Abedin
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2020, 25 (02) : 206 - 218
  • [32] Design and development of 5-fluorouracil loaded biodegradable magnetic microspheres as site-specific drug delivery vehicle for cancer therapy
    Ayyanaar, Srinivasan
    Bhaskar, R.
    Esthar, Selvaraj
    Vadivel, Manokaran
    Rajesh, Jegathalaprathaban
    Rajagopal, Gurusamy
    Journal of Magnetism and Magnetic Materials, 2022, 546
  • [33] Design and development of 5-fluorouracil loaded biodegradable magnetic microspheres as site-specific drug delivery vehicle for cancer therapy
    Ayyanaar, Srinivasan
    Bhaskar, R.
    Esthar, Selvaraj
    Vadivel, Manokaran
    Rajesh, Jegathalaprathaban
    Rajagopal, Gurusamy
    JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2022, 546
  • [34] Stomach-specific drug delivery of 5-Fluorouracil using ethylcellulose floating microspheres
    Vaghani, Subhash
    Vasanti, S.
    Chaturvedi, Kiran
    Satish, C. S.
    Jivani, N. P.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2010, 15 (02) : 154 - 161
  • [35] Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads
    Shishu
    Gupta N.
    Aggarwal N.
    AAPS PharmSciTech, 8 (2)
  • [36] Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads
    Shishu
    Gupta, Neeta
    Aggarwal, Nidhi
    AAPS PHARMSCITECH, 2007, 8 (02):
  • [37] Core Cross-linked Star Polymers for Temperature/pH Controlled Delivery of 5-Fluorouracil
    Sanchez-Bustos, Elizabeth
    Cornejo-Bravo, Jose M.
    Licea-Claverie, Angel
    JOURNAL OF CHEMISTRY, 2016, 2016
  • [38] Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity
    Mohammadian, Samaneh
    Khazaei, Majid
    Maghami, Parvaneh
    Avan, Amir
    Rezaei, Majid
    CURRENT CANCER DRUG TARGETS, 2023, 23 (07) : 524 - 533
  • [39] Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer
    Haiping Jiang
    Xinyan Shi
    Xiaoyun Yu
    Xinjia He
    Yongheng An
    Haijun Lu
    Pharmaceutical Research, 2018, 35
  • [40] Chitosan Nanoparticles of 5-Fluorouracil for Ophthalmic Delivery: Characterization, in-Vitro and in-Vivo Study
    Nagarwal, Ramesh Chand
    Singh, Paras Nath
    Kant, Shri
    Maiti, Pralay
    Pandit, Jayanta Kumar
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2011, 59 (02) : 272 - 278